On December 17, 2018 Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) reported that its management will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, USA (Press release, Evotec, DEC 17, 2018, View Source;announcements/press-releases/p/evotec-to-present-at-jp-morgan-healthcare-conference-5757 [SID1234532105]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

37th J.P. Morgan Healthcare Conference, San Francisco, USA

Date: Thursday, 10 January 2019,Presentation: 10 January 2019, 08.00 am PT (11.00 am EST, 04.00 pm GMT, 05.00 pm CET)

Webcast: The webcast link will be made available at the Company’s website

Venue: San Francisco, USA

Attendee: Dr Werner Lanthaler, Chief Executive Officer